Loading chat...
NJ A3197
Bill
Status
1/9/2024
Primary Sponsor
Aura Dunn
Click for details
AI Summary
-
Increases annual funding for the New Jersey Commission on Cancer Research from $1 million to $4 million, sourced from cigarette and other tobacco products tax revenues
-
Establishes a new non-lapsing, revolving Cancer Research Fund within the Department of the Treasury to replace the existing lapsing fund
-
Fund monies, including interest earned, must be used exclusively for cancer research grants approved by the commission and other authorized commission responsibilities
-
State Treasurer serves as custodian of the fund, with disbursements made upon vouchers signed by the commission chairperson or designee
-
Aligns cancer research funding with State funding levels for spinal cord and brain injury research, which receive approximately $4-6 million annually
Legislative Description
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.
Health
Last Action
Introduced, Referred to Assembly Health Committee
1/9/2024